Virus World
379.9K views | +8 today
Follow
Virus World
Virus World provides a daily blog of the latest news in the Virology field and the COVID-19 pandemic. News on new antiviral drugs, vaccines, diagnostic tests, viral outbreaks, novel viruses and milestone discoveries are curated by expert virologists. Highlighted news include trending and most cited scientific articles in these fields with links to the original publications. Stay up-to-date with the most exciting discoveries in the virus world and the last therapies for COVID-19 without spending hours browsing news and scientific publications. Additional comments by experts on the topics are available in Linkedin (https://www.linkedin.com/in/juanlama/detail/recent-activity/)
Curated by Juan Lama
Your new post is loading...
Scooped by Juan Lama
Scoop.it!

Biden Administration Offers U.S. Households More Free COVID-19 Tests for Winter

Biden Administration Offers U.S. Households More Free COVID-19 Tests for Winter | Virus World | Scoop.it

WASHINGTON, Dec 15 (Reuters) - U.S. households can order four free at-home COVID-19 tests from the government website COVIDTests.gov beginning on Thursday as part of the Biden administration's efforts to tackle coronavirus infections over the winter. The White House said it would use existing funding to pay for the tests since it has been unsuccessful so far in getting Congress to pass a bill to put more money toward the U.S. COVID-19 response. The free tests program was paused because officials wanted to make sure there were enough tests available for a likely spike in COVID cases in the winter, White House COVID-19 response coordinator Ashish Jha said. "We knew there will be a moment later in the year when COVID cases would rise again. So we preserved the tests so we could have them on hand for exactly this moment," White House COVID-19 response coordinator Ashish Jha said on Thursday. "And if we don't get more funding, we won't be able to send more tests out to the American people."

 

White House Press Release (Dec. 15, 2022):

https://www.whitehouse.gov/briefing-room/statements-releases/2022/12/15/fact-sheet-biden-administration-announces-covid-19-winter-preparedness-plan/ 

Marry J's curator insight, December 16, 2022 1:08 PM

buyrickandmortytrippyflp.com

Marry J's curator insight, December 16, 2022 1:26 PM

buyrickandmortytrippyflp.com

Scooped by Juan Lama
Scoop.it!

Flu Hospitalizations are Rising Dramatically, and Earlier than Ever, CDC Says

Flu Hospitalizations are Rising Dramatically, and Earlier than Ever, CDC Says | Virus World | Scoop.it

Flu-related hospitalizations nationwide have risen dramatically in recent weeks, reaching levels historically not seen until much later in flu season, according to data released Friday by the Centers for Disease Control and Prevention. "We haven't seen this level of activity this early before," said Lynnette Brammer, team lead of the domestic influenza surveillance team at the CDC. Typical flu seasons usually don't pick up steam until December. Flu hospitalizations are rising across all age groups, especially children. The increase comes as other respiratory viruses, including RSV, or respiratory syncytial virus, are also spiking in kids. According to the Department of Health and Human Services, 76% of pediatric hospital beds nationwide are full. "We realize the potential implications of the co-circulating viruses all at once," Brammer said. "We're taking it very seriously."  Doctors are not required to report each positive flu test to public health officials, so the CDC and others monitor likely flu activity by looking at "influenza-like illnesses": a fever of at least 100 degrees Fahrenheit and a cough and/or sore throat without any other known cause.

 

Also Friday, the CDC reported the first flu-related death in a child so far this season. The CDC did not provide any details about the child, however KVEO, the NBC affiliate in Brownsville, Texas, recently reported that a 3-year-old girl had died after testing positive for the flu. While the flu and similar viral illnesses are rising nationwide, they're notably high across the Southeast and Eastern Seaboard — from Texas to Georgia, and South Carolina up to Virginia and New Jersey, according to the new report. Doctors also warn that other infections can follow severe cases of the flu, including bacterial infections like pneumococcal pneumonia. Dr. Greg Poland, director of the Mayo Clinic's Vaccine Research Group in Rochester, Minnesota, worries that this season could be bad for these post-viral infections.  Dr. Shannon Martinello, a pediatrician in private practice in New Haven, Connecticut, is already seeing an uptick in post-viral bacterial illness. "The more mucus they have, and the more congested they are, it increases their risk of ear infections," she said. "I always tell parents when their kids have flu, it's going to be a rough week, and they're going to get better," Martinello said. But if a child who has recovered from the flu starts to feel sick again a week or 10 days later, she advises parents to take the child back to the doctor. "I want to re-listen to his lungs and re-check his ears and make sure that something else hasn't happened as a secondary issue." 

 

There are early signs that this year's flu shot appears to work well at keeping people out of the hospital. A report on Chile's flu season, released Thursday by the CDC, found the vaccine was 49% protective against flu-related hospitalizations. That might seem low, but from 2015 to 2020, flu shot effectiveness in the U.S. ranged from 29% to 48%.  It's unclear whether this year's flu shots in the U.S. will be as effective as was found during Chile's flu season. But the shots used in both countries have one of the same targets: the H3N2 flu strain, which accounts for a majority of flu cases currently detected in the U.S. H3N2 is an influenza A virus and is often associated with increased hospitalizations. Kids under age 5 may be at particular risk. The CDC recommends that everyone 6 months and older get an annual flu shot. Children up through 8 years old may need two shots this year, the agency said, especially if they've never had the flu vaccine. The American Academy of Pediatrics has the same recommendation, adding that kids should get their flu shots by the end of October. But the early start to the flu season has left many Americans vulnerable. Only about half of the population gets an annual flu shot, typically. Many who do often wait until October to get it. "I cannot stress enough how important it is to go ahead and get that vaccine now," Brammer said.

No comment yet.
Scooped by Juan Lama
Scoop.it!

F.D.A. Authorizes Updated Covid Booster Shots, Targeting Omicron Subvariants - The New York Times

F.D.A. Authorizes Updated Covid Booster Shots, Targeting Omicron Subvariants - The New York Times | Virus World | Scoop.it

WASHINGTON — The Food and Drug Administration on Wednesday authorized the first redesign of coronavirus vaccines since they were rolled out in late 2020, setting up millions of Americans to receive new booster doses targeting Omicron subvariants as soon as next week. The agency cleared two options aimed at the BA.5 variant of Omicron that is now dominant: one made by Pfizer and its German partner BioNTech for use in people as young as 12, and the other by Moderna, for those 18 and older. The doses can be given at least two months since people last received a booster dose or completed their initial series of vaccinations. Biden administration officials have argued that even as researchers work to understand how protective the new shots might be, inoculating Americans again in the coming weeks could help curb the persistently high number of infections and deaths. “As we head into fall and begin to spend more time indoors, we strongly encourage anyone who is eligible to consider receiving a booster dose,” Dr. Robert M. Califf, the F.D.A. commissioner, said in a statement on Wednesday. He added that the vaccine would “provide better protection against currently circulating variants.” An average of about 90,000 infections and 475 deaths are recorded every day around the United States, almost three years into a pandemic that has killed more than a million Americans and driven a historic drop in life expectancy. But there are also hopeful signs. Even with high case counts, fewer than 40,000 people are currently hospitalized with the virus, a decrease of 10 percent since early August and far fewer than during the Delta-driven surge last summer or the Omicron-fueled wave last winter. Deaths have also remained somewhat flat in recent weeks, a sign that vaccines are helping to prevent the worst outcomes of Covid-19. Ample evidence suggests that many Americans will hold back from getting the updated boosters, either because they are weary of the pandemic or may not feel urgency about an additional dose. With each new shot offered, there are fewer takers.

 

As more companies bring workers back to offices and students return to campuses this fall, persuading Americans to get the updated booster shots will be a major challenge for the administration. The companies produced the retooled shots with extraordinary speed, a testament to the mRNA technology that Pfizer and Moderna have harnessed since the early months of the coronavirus outbreak. The Food and Drug Administration advised companies only two months ago on the formulation that they should adopt for the new vaccines. By later this week, millions of those doses will be delivered to states. The tight timeline meant that the companies went to federal regulators this summer with more limited data on the redesigned boosters than a traditional review process would call for, generating some controversy. Regulators authorized the vaccine without results from human trials, which have just started. Federal officials argue that because the coronavirus is evolving so quickly, human trials would be out of date before they can deliver results that could be used in the F.D.A.’s authorization decision. Instead, they are relying on the results of mouse trials and earlier human trials by Pfizer and Moderna of reformulations aimed at previous versions of the virus. The Biden administration is casting the shots as a standard upgrade that Americans should embrace ahead of potential surges in cases in the winter, like the flu shot, which is reconfigured every year to target more current versions of the influenza virus. The boosters are arriving during a period when the White House has been largely quiet on the pandemic. President Biden has rarely commented on the coronavirus in recent months, even after he tested positive in July. The White House no longer holds regular news briefings on the federal pandemic response, as it did in the first year of the administration — a reflection of the weariness of many Americans in keeping up with Covid precautions. “Covid-19 is the third leading cause of death in the United States. And it’s as if we’ve just accepted that that is going to be the case,” said Mercedes Carnethon, an epidemiologist at Northwestern University’s Feinberg School of Medicine. “I really hope as many people as possible will seek the updated booster so we can protect those who will have a terrible outcome.”

 

Vaccinations remain the cornerstone of the federal government’s Covid strategy, even with tests and treatments widely available. The Biden administration has ordered over 170 million doses for the fall campaign, and officials do not expect shortages when they are rolled out. “If it’s freezing cold out and you have children, you’re going to dress them warmly. This is the concept here,” said Dr. Paul G. Auwaerter, the clinical director of the infectious diseases division at the Johns Hopkins University School of Medicine. “You’ll want to head into the respiratory season with a virus that we know has surprised us with a booster.” Exactly how protective the shots might be is unknown, Dr. Auwaerter said. He pointed to the modest increases in neutralizing antibodies that the companies found in vaccines they tested this year that targeted the original form of Omicron. How antibody levels would translate to protection with the new vaccines was unclear, he added. Experts warned against trying to choose Moderna’s shot over Pfizer’s or vice versa; with research in humans just beginning, scientists are months from knowing whether one brand offers better protection than the other. Many Americans have recently been infected with variants in the Omicron family and have some protection from their bouts with the virus, a development that federal agencies may take into account when recommending how the new shots are used. An advisory committee to the Centers for Disease Control and Prevention is scheduled to meet this week to make recommendations. “For most people, the risk of death is so low at this point, because they’ve gotten infected or vaccinated, or more likely both,” said Dr. Gregory A. Poland, a professor of medicine and infectious diseases and the director of the Vaccine Research Group at the Mayo Clinic. Dr. Poland, who has advised Moderna, Pfizer and White House officials on coronavirus vaccines, said updating booster shots the way the Food and Drug Administration did on Wednesday amounted to a “chase your tail” strategy, tweaking the design incrementally to try to keep up with a fast-changing virus. The new boosters, he said, could potentially save some lives among the elderly and those with immune deficiencies. But they were unlikely to make as substantial an impact with the rest of the population.

 
No comment yet.
Scooped by Juan Lama
Scoop.it!

With Hospitalizations Ticking Up, Flu Season Appears Off to Early Start

With Hospitalizations Ticking Up, Flu Season Appears Off to Early Start | Virus World | Scoop.it

The cumulative hospitalization rate for flu in the U.S. is higher than it has been at this point for more than a decade. There are increasing signs that flu season is off to a very early start in parts of the United States, with the cumulative hospitalization rate higher than it has been at this point in the fall for more than a decade, the Centers for Disease Control and Prevention reported Friday.  In its weekly FluView report, the CDC estimated that there have already been 880,000 influenza illnesses, 6,900 flu hospitalizations, and 360 deaths caused by flu this season, which started at the beginning of October. It is unusual for the CDC to have enough data to issue estimates on the burden of flu this early in the season.  These figures are estimates, based on data from a flu hospitalization surveillance network of acute care hospitals in 14 states. Flu activity is currently highest in south-central and southeast parts of the country, and New York. It is also picking up along the Eastern Seaboard. The CDC also reported the death of a child, the first pediatric flu death of the new flu season. It occurred in the week ending Oct. 8. 

 

In the first two winters of the Covid-19 pandemic, the new coronavirus and the measures people took to protect themselves from it suppressed transmission of a number of respiratory pathogens that normally make the rounds. That hiatus has ended and those viruses are returning, though often at times when they didn’t normally circulate in the past. Hospitals around the country are seeing record numbers of cases of respiratory syncytial virus, or RSV, right now. In pre-Covid times, RSV didn’t typically emerge until the winter. Some people are interpreting the early start of flu activity as evidence we are in for a harsh flu season. But Lynnette Brammer, team lead for domestic surveillance in the CDC’s influenza division, said it’s impossible at this point to know how bad the season will be.  “What a lot of people are implying is because it’s early and levels are high for this time of year that it’s going to be a severe season. We don’t know that,” Brammer told STAT.  “Right now all we can say is we’re off to an early start.”  She noted that people who have been waiting to get a flu shot to try to time it to the start of flu circulation should not hold off any longer. “You need to get vaccinated now, if you haven’t already done that.” Ed Belongia, director of the Center for Clinical Epidemiology and Population Health at Wisconsin’s Marshfield Clinic Research Institute, said there is good reason to be worried that this could be a severe flu season. Most immune systems haven’t seen flu viruses for a couple of years, which means the pool of people susceptible to infection is large. And the measures society took to try to slow spread of Covid — mask-wearing, social distancing, school closures — have mostly been abandoned.  But Belongia has been studying flu for too long to guess how a flu season will unfold. The virus is maddeningly unpredictable. “Whether or not the whole season is going to be longer and more severe, we really just don’t know at this point. It’s too early to say,” he said.

 

Evidence from the Southern Hemisphere’s flu season — which sometimes provides hints of what’s in store for us — showed oddly timed and active flu seasons, but not necessarily bad ones. Australia had a lot of flu activity, mainly in children. But a report on its 2022 winter season issued earlier this month stated that the clinical severity of the season, based on the numbers of intensive care admissions and deaths, was actually low. It rated the overall impact of the flu season as low to moderate. Other hopeful news from the Southern Hemisphere was that the flu vaccine seems well-matched to the viruses that are circulating. A report this week from Chile in the CDC’s online journal Morbidity and Mortality Weekly Report estimated flu vaccine efficacy at 49% against H3N2 viruses, the subtype that caused most of the disease there. It is also the virus currently causing most disease in the U.S. Belongia said he was pleasantly surprised, adding  “49% is about as good as you can expect to see for H3N2. So I thought that was encouraging. While it’s impossible to guess how bad the flu season will be, there is one thing that does look reasonable to assume. If the current levels of circulation of influenza and RSV virus continue or increase, there could be a lot of respiratory illness around Thanksgiving. Much of the current illness is in young children, who typically get sick first in the cold and flu season and spread their bugs to siblings, parents, grandparents, and other adults with whom they are in contact.

 
No comment yet.
Scooped by Juan Lama
Scoop.it!

Technical Report 2: Multi-National Monkeypox Outbreak, United States, 2022 | Monkeypox | Poxvirus | CDC

Technical Report 2: Multi-National Monkeypox Outbreak, United States, 2022 | Monkeypox | Poxvirus | CDC | Virus World | Scoop.it

Monkeypox is a viral disease that occurs mostly in central and western Africa. It is called monkeypox because it was first identified in laboratory monkeys. However, it is much more common among animals such as rats, mice, rabbits, and the African Squirrel.

 

This is a technical report intended for scientific audiences. Additional information, including materials targeted to the general public, are available on the monkeypox site. The purpose of this report is to provide timely updates regarding CDC’s ongoing response to the monkeypox (MPX) outbreak in the United States, and to share preliminary results of new analyses that can improve understanding of the outbreak and inform further scientific inquiry.  This report is intended for a technical audience; each report features a combination of standing topics and the results of special analyses. Additional information about the status of the outbreak, guidance, and information for the general public can be accessed at CDC’s monkeypox outbreak response page.

 

Published August 26, 2022

No comment yet.